Philip K. Yachmetz, EVP, Chief Business Officer at SAVIENT PHARMACEUTICALS INC (SVNT), sold 3,785 shares at $19.00 ($72K) on 2008-04-14, disclosed to the SEC on 2008-04-16.
Scheduled sale ($72k) by EVP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SVNT | SELL | 2013-01-16 | $1K | — | Filing → |
| SVNT | SELL | 2012-02-23 | $7K | — | Filing → |
| SVNT | BUY | 2011-09-16 | $29K | — | Filing → |